The revenue stands at ₹3,567.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.52 per cent from ₹3,697.16 crore. This corresponds to a year-on-year *(YoY) growth of 11.52 per cent.
Operating Profit stands at ₹812.84 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.78 per cent from ₹921.33 crore. This corresponds to a year-on-year *(YoY) decline of 0.39 per cent.
PBDT stands at ₹731.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.51 per cent from ₹845.84 crore. This corresponds to a year-on-year *(YoY) growth of 7.25 per cent.
Profit Before Tax stands at ₹509.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.43 per cent from ₹624.02 crore. This corresponds to a year-on-year *(YoY) growth of 2.83 per cent.
Net Profit stands at ₹413.88 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 20.44 per cent from ₹520.18 crore. This represents a 7.64 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Mankind Pharma | 2.81% | 3.46% | 16.00% | 24.47% | 13.55% | 0.55% |
| Cipla | -0.25% | -2.23% | 14.08% | 6.06% | -6.94% | -5.10% |
| Dr Reddy's Labs | -0.42% | 1.96% | 8.82% | 1.64% | 6.74% | 8.46% |
| Zydus Lifesci. | 3.67% | 6.56% | 13.73% | 16.35% | 14.26% | 18.72% |
| Lupin | 0.08% | 1.36% | -1.01% | 1.93% | 12.80% | 14.67% |
| Aurobindo Pharma | 0.50% | 0.88% | 9.48% | 32.43% | 26.36% | 26.50% |
| Laurus Labs | 0.77% | 3.31% | 21.95% | 33.64% | 39.04% | 127.64% |
Chairman & Wholetime Director : RAMESH CHAND JUNEJA
Vice Chairman & Managing Director : RAJEEV JUNEJA
Whole Time Director & Chief Executive Officer : SHEETAL ARORA
Independent Director : TILOKCHAND PUNAMCHAND OSTWAL
Independent Director : Bharat Anand
Whole-time Director : SATISH KUMAR SHARMA
Independent Director : Vivek Kalra
Independent Director : Vijaya Sampath
Company Sec. & Compli. Officer : Hitesh Kumar Jain